The relationship of alexithymia with difficulty in emotional regulation, anxiety, and depression symptoms in a group of patients receiving opioid maintenance treatment

Basit Öğe Kaydı
dc.authoridKarabulut, Vahap/0000-0001-7957-9016;
dc.contributor.authorKarabulut, Vahap
dc.contributor.authorEvren, Cüneyt
dc.contributor.authorAlnıak, İzgi
dc.contributor.authorÇarkcı, Özlem Helin
dc.contributor.authorYılmaz Çengel, Hanife
dc.date.accessioned2024-09-11T19:53:48Z
dc.date.available2024-09-11T19:53:48Z
dc.date.issued2021
dc.departmentİstanbul Gelişim Üniversitesien_US
dc.description.abstractBackground: The purpose of this study was to evaluate the relationship between alexithymia and emotion regulation difficulties in a group of patients receiving opioid (buprenorphine). Methods: The study was directed to the problems of inpatients in the Alcohol and Substance Dependence Service of Bakirkoy Mental and Nervous Diseases Training and Research Hospital. Data from 90 patients with opioid use disorders were evaluated. The following scales were adminstered to each of the patients participating: the State-Trait Anxiety Inventory I-II (STAI I-II), Beck's Depression Inventory (BDI), Difficulties in Emotion Regulation Scale (DERS), and Toronto Alexithymia Scale (TAS-20). Results: 54.4% of the patients were found to have alexithymia or possible alexithymia. There were no statistically significant differences between those who had alexithymia and those who were free of it in terms of age, years of education, age at first substance use, duration of heroin use, marital status, and employment status. The alexithymic patients scored significantly higher than the non-alexithymic patients on DERS (104.35 +/- 16.70 vs. 77.88 +/- 12.48, p>0.001), STAI-I (37.69 +/- 9.42 vs. 33.15 +/- 6.68, p=0.009), and STAI-II (50.10 +/- 7.27 vs. 40.20 +/- 6.29, p>0.001). The BDI scores (17.81 +/- 12.40 vs. 11.31 +/- 12.90, p=0.056) did not differ significantly between the two groups. The MANCOVA analysis showed that difficulty in identifying feelings as a subdimension of alexithymia was predicted by trait anxiety and the awareness, strategies, and clarity subscales of DERS, and the externally-oriented thinking subdimension of alexithymia was predicted by the awareness subscale of DERS. Linear regression analysis showed that difficulty in emotion regulation (with special reference to clarity, strategies, and goals subscales), taken together with trait anxiety, predicted the severity of alexithymia. Conclusions: Our findings indicate that, in particular, the clarity, strategies, and goal subscales of DERS, along with trait anxiety, are associated with the severity of alexithymia in those with opioid use disorder who are receiving maintenance therapy with buprenorphine.en_US
dc.identifier.endpage21en_US
dc.identifier.issn1592-1638
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85109811775en_US
dc.identifier.startpage13en_US
dc.identifier.urihttps://hdl.handle.net/11363/8203
dc.identifier.volume23en_US
dc.identifier.wosWOS:000658725900003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherPacini Editoreen_US
dc.relation.ispartofHeroin Addiction And Related Clinical Problemsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240903_Gen_US
dc.subjectOpiateen_US
dc.subjectbuprenorphineen_US
dc.subjectalexithymiaen_US
dc.subjectdifficulty in emotion regulationen_US
dc.subjectanxietyen_US
dc.subjectdepressionen_US
dc.titleThe relationship of alexithymia with difficulty in emotional regulation, anxiety, and depression symptoms in a group of patients receiving opioid maintenance treatmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu